Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters

Introduction  Cancer immunotherapy targeting the programmed cell death ligand 1 (PD-L1) and programmed cell death-1 (PD-1) axis has revolutionized cancer therapy. PD-L1 also serves as a predictive marker for such therapy. To assess the potential of such therapy in any cancer, the positivity of PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehan, Anoushika, Anthony, Michael Leonard, Paul, Pranoy, Syed, Anjum, Chowdhury, Nilotpal, Rao, Shalinee, Hussain, Nuzhat, Ravi, Bina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519265/
https://www.ncbi.nlm.nih.gov/pubmed/36186259
http://dx.doi.org/10.1055/s-0041-1736522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519265/
https://www.ncbi.nlm.nih.gov/pubmed/36186259
http://dx.doi.org/10.1055/s-0041-1736522

Ejemplares similares